Page last updated: 2024-09-04

birb 796 and pd 180970

birb 796 has been researched along with pd 180970 in 1 studies

Compound Research Comparison

Studies
(birb 796)
Trials
(birb 796)
Recent Studies (post-2010)
(birb 796)
Studies
(pd 180970)
Trials
(pd 180970)
Recent Studies (post-2010) (pd 180970)
13758031012

Protein Interaction Comparison

ProteinTaxonomybirb 796 (IC50)pd 180970 (IC50)
Chain A, Proto-oncogene tyrosine-protein kinase ABL1Homo sapiens (human)0.07
Chain A, Proto-oncogene tyrosine-protein kinase ABL1Homo sapiens (human)0.07
Chain A, Proto-oncogene tyrosine-protein kinase ABL1Homo sapiens (human)0.07
Chain A, Proto-oncogene tyrosine-protein kinase ABL1Homo sapiens (human)0.07
Chain A, Proto-oncogene tyrosine-protein kinase ABL1Mus musculus (house mouse)0.07
Epidermal growth factor receptorHomo sapiens (human)0.39
Tyrosine-protein kinase LckHomo sapiens (human)0.4782
Platelet-derived growth factor receptor betaHomo sapiens (human)0.7632
Fibroblast growth factor receptor 1Homo sapiens (human)0.664
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.4805
Platelet-derived growth factor receptor alphaHomo sapiens (human)1.43
Activin receptor type-1Homo sapiens (human)1
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinaseHomo sapiens (human)1.4045

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atteridge, CE; Biggs, WH; Carter, TA; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Grotzfeld, RM; Herrgard, S; Insko, DE; Lockhart, DJ; Mehta, SA; Milanov, ZV; Pao, W; Patel, HK; Sawyers, CL; Shah, NP; Treiber, DK; Varmus, H; Velasco, AM; Wodicka, LM; Zarrinkar, PP1

Other Studies

1 other study(ies) available for birb 796 and pd 180970

ArticleYear
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-02, Volume: 102, Issue:31

    Topics: Aminoquinolines; Aniline Compounds; Cell Line; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Indoles; Kinetics; Morpholines; Mutation; Naphthalenes; Neoplasms; Oncogene Proteins v-abl; Organic Chemicals; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Sunitinib

2005